MediWound Ltd. logo
MediWound Ltd. MDWD
$ 13.51 0.22%

MediWound Ltd. Net Income | MDWD

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income MediWound Ltd.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-9.2 M 4.96 M -1.06 M -22.1 M -18.9 M -22.1 M -18.9 M -15.4 M 10.9 M -6.17 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
10.9 M -22.1 M -9.79 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
Praxis Precision Medicines Praxis Precision Medicines
PRAX
-303 M $ 283.56 3.0 % $ 6.38 B usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
-5.02 M $ 0.88 0.04 % $ 570 K israelIsrael
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
-99.5 M $ 3.77 2.72 % $ 290 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
-42.2 M $ 1.67 2.14 % $ 176 M niderlandNiderland
Prothena Corporation plc Prothena Corporation plc
PRTA
-244 M $ 8.27 0.35 % $ 445 M usaUSA
PTC Therapeutics PTC Therapeutics
PTCT
683 M $ 63.65 0.3 % $ 5.06 B usaUSA
Protagonist Therapeutics Protagonist Therapeutics
PTGX
-130 M $ 140.63 0.41 % $ 8.94 B usaUSA
Pulmatrix Pulmatrix
PULM
-1.17 M $ 1.48 0.64 % $ 5.41 B usaUSA
PolyPid Ltd. PolyPid Ltd.
PYPD
-34.2 M $ 5.2 0.19 % $ 85 M israelIsrael
Repare Therapeutics Repare Therapeutics
RPTX
-84.7 M - - $ 112 M canadaCanada
uniQure N.V. uniQure N.V.
QURE
-199 M $ 22.8 0.39 % $ 1.31 B niderlandNiderland
Rocket Pharmaceuticals Rocket Pharmaceuticals
RCKT
-223 M $ 2.61 1.95 % $ 290 M usaUSA
Arcus Biosciences Arcus Biosciences
RCUS
-353 M $ 24.74 1.23 % $ 2.66 B usaUSA
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
4.5 B $ 726.47 0.05 % $ 76 B usaUSA
Replimune Group Replimune Group
REPL
-314 M $ 13.15 0.61 % $ 1.22 B usaUSA
Rafael Holdings Rafael Holdings
RFL
-290 K $ 1.47 0.65 % $ 43.3 M usaUSA
REGENXBIO REGENXBIO
RGNX
-194 M $ 7.76 4.44 % $ 400 M usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
367 M $ 47.79 1.36 % $ 860 M usaUSA
Relay Therapeutics Relay Therapeutics
RLAY
-276 M $ 19.39 2.27 % $ 3.33 B usaUSA
Avidity Biosciences Avidity Biosciences
RNA
-685 M $ 7.97 1.66 % $ 1.1 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
771 M $ 56.66 0.36 % $ 24.4 B usaUSA
Revolution Medicines Revolution Medicines
RVMD
-1.13 B $ 207.68 0.5 % $ 39.5 B usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
-197 K $ 92.45 0.24 % $ 6.01 B usaUSA
Rezolute Rezolute
RZLT
-77.6 M $ 4.33 7.98 % $ 450 M usaUSA
Sana Biotechnology Sana Biotechnology
SANA
-244 M $ 2.88 1.21 % $ 729 M usaUSA
Seer Seer
SEER
-73.6 M $ 2.33 3.56 % $ 129 M usaUSA
SIGA Technologies SIGA Technologies
SIGA
23.3 M $ 3.48 2.96 % $ 249 M usaUSA
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
-6.13 M $ 78.95 9.65 % $ 220 M israelIsrael
Silence Therapeutics plc Silence Therapeutics plc
SLN
-43.3 M $ 10.14 0.78 % $ 1.44 B britainBritain
SELLAS Life Sciences Group SELLAS Life Sciences Group
SLS
-26.9 M $ 11.63 3.62 % $ 1.27 B usaUSA
Summit Therapeutics Summit Therapeutics
SMMT
-1.08 B $ 17.27 3.07 % $ 12.9 B britainBritain
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
-285 M $ 17.83 1.31 % $ 1.54 B usaUSA
Soligenix Soligenix
SNGX
-11.1 M $ 0.36 0.6 % $ 1.87 M usaUSA
Sanofi Sanofi
SNY
7.85 B $ 39.51 1.19 % $ 48.2 B franceFrance
Spruce Biosciences Spruce Biosciences
SPRB
-39 M $ 45.42 2.1 % $ 34.8 M usaUSA
Spero Therapeutics Spero Therapeutics
SPRO
8.57 M $ 1.16 4.13 % $ 65 M usaUSA
Sarepta Therapeutics Sarepta Therapeutics
SRPT
-713 M $ 17.49 0.7 % $ 1.75 B usaUSA
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
-378 M $ 43.4 1.41 % $ 4.98 B usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
-6.88 M $ 25.32 0.8 % $ 1.5 B usaUSA
Sutro Biopharma Sutro Biopharma
STRO
-191 M $ 15.13 0.23 % $ 129 M usaUSA
Shattuck Labs Shattuck Labs
STTK
-48.8 M $ 6.5 1.04 % $ 452 M usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
-38.6 M $ 42.76 0.9 % $ 2.41 B usaUSA
Sesen Bio Sesen Bio
SESN
-60.5 M - 7.29 % $ 127 M usaUSA
Savara Savara
SVRA
-119 M $ 4.78 0.1 % $ 1.06 B usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
-6.21 M $ 2.08 1.99 % $ 1.41 M chinaChina
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
TAK
108 B $ 17.81 0.08 % $ 28.1 B japanJapan
Protara Therapeutics Protara Therapeutics
TARA
-57.4 M $ 2.63 0.36 % $ 113 M usaUSA
Tarsus Pharmaceuticals Tarsus Pharmaceuticals
TARS
-66 M $ 74.46 1.99 % $ 3.11 B usaUSA
Bio-Techne Corporation Bio-Techne Corporation
TECH
182 M $ 72.58 0.25 % $ 11.3 B usaUSA
Tenax Therapeutics Tenax Therapeutics
TENX
-52.6 M $ 1.96 2.59 % $ 76.9 M usaUSA